0R15 9025.0 0.0% 0R1E 9410.0 0.0% 0M69 None None% 0R2V 247.99 9682.643% 0QYR 1567.5 0.0% 0QYP 439.3701 -2.9016% 0RUK None None% 0RYA 1597.0 1.2682% 0RIH 195.55 0.0% 0RIH 191.4 -2.1222% 0R1O 225.5 9683.0803% 0R1O None None% 0QFP 10475.8496 107.8542% 0M2Z 252.573 0.2373% 0VSO 33.0 -7.3164% 0R1I None None% 0QZI 622.0 0.0% 0QZ0 220.0 0.0% 0NZF None None% 0YXG 222.05 -4.1318%
Last update at 2024-12-19T16:30:00Z
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown |
|---|
Sector: Healthcare Industry: Medical Devices
| Company | Change (GBP) | Price (GBP) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NIOX NIOX Group PLC |
1.00 1.61% | 63.00 | 32.00 | 20.75 | 7.92 | 3.40 | 7.31 | 28.40 |
| SN Smith & Nephew PLC |
-3.4 0.35% | 977.20 | 53.70 | 14.27 | 1.75 | 2.26 | 2.21 | 13.21 |
| MXCT MaxCyte Inc |
-23.0 6.65% | 323.00 | - | - | 10.41 | 2.15 | 6.75 | -6.5763 |
| EKF EKF Diagnostics Holdings Plc |
-1.1 4.38% | 24.00 | - | - | 2.40 | 2.09 | 2.25 | -19.3996 |
| CREO Creo Medical Group PLC |
0.75 4.62% | 17.00 | - | - | 4.53 | 1.91 | 3.91 | -4.68 |
NIOX Group Plc, a diagnostics and management company, design, development, and commercialization of medical devices for the measurement of fractional exhaled nitric oxide (FeNo) worldwide. Its products include NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of FeNo in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
Hayakawa Building, Oxford, United Kingdom, OX4 4GB
| Name | Title | Year Born |
|---|---|---|
| Mr. Ian Roy Johnson | Exec. Chairman | 1954 |
| Mr. Michael Roy David Roller A.C.A., ACA, BA (Hons) | CFO & Director | 1965 |
| Mr. Jonathan Emms | COO & Exec. Director | NA |
| Ms. Nina Kataria | Sr. VP Global HR | NA |
| Mr. Tom Scaccia | Sr. VP of Americas & Research Bus. | NA |
| Ms. Sarah Duncan | Company Sec. | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
UK 
AU
CA
US
NZ
Please wait processing your request...